메뉴 건너뛰기




Volumn 128, Issue 12 PART 1, 1998, Pages 975-981

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation: A randomized, double-blind, placebo-controlled trial

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BUSULFAN; CYCLOSPORIN; METHOTREXATE; URSODEOXYCHOLIC ACID; VANCOMYCIN;

EID: 17344386370     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-12_part_1-199806150-00002     Document Type: Article
Times cited : (171)

References (37)
  • 2
    • 0022471192 scopus 로고
    • Hepatic veno-occlusive disease
    • Rollins BJ. Hepatic veno-occlusive disease. Am J Med. 1986;81:297-306.
    • (1986) Am J Med. , vol.81 , pp. 297-306
    • Rollins, B.J.1
  • 3
    • 0021363719 scopus 로고
    • Venoocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors
    • McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116-22.
    • (1984) Hepatology , vol.4 , pp. 116-122
    • McDonald, G.B.1    Sharma, P.2    Matthews, D.E.3    Shulman, H.M.4    Thomas, E.D.5
  • 4
    • 0023584421 scopus 로고
    • Preparative regimens for marrow transplantation containing busulfan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis
    • Atkinson K, Biggs J, Noble G, Ashby M, Concannon A, Dodds A. Preparative regimens for marrow transplantation containing busulfan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant. 1987;2:385-94.
    • (1987) Bone Marrow Transplant. , vol.2 , pp. 385-394
    • Atkinson, K.1    Biggs, J.2    Noble, G.3    Ashby, M.4    Concannon, A.5    Dodds, A.6
  • 5
    • 0026748596 scopus 로고
    • Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide
    • Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Johnson RA, et al. Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. Blood. 1992;79:2784-8.
    • (1992) Blood , vol.79 , pp. 2784-2788
    • Essell, J.H.1    Thompson, J.M.2    Harman, G.S.3    Halvorson, R.D.4    Snyder, M.J.5    Johnson, R.A.6
  • 6
    • 0027326608 scopus 로고
    • A phase I/II study of prostaglandin E1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation
    • Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB. A phase I/II study of prostaglandin E1 for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Br J Haematol. 1993;84:724-30.
    • (1993) Br J Haematol. , vol.84 , pp. 724-730
    • Bearman, S.I.1    Shen, D.D.2    Hinds, M.S.3    Hill, H.A.4    McDonald, G.B.5
  • 7
    • 0026720385 scopus 로고
    • Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial
    • Attal M, Huguet F, Rubie H, Huynh A, Charlet JP, Payen JL, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood. 1992;79:2834-40.
    • (1992) Blood , vol.79 , pp. 2834-2840
    • Attal, M.1    Huguet, F.2    Rubie, H.3    Huynh, A.4    Charlet, J.P.5    Payen, J.L.6
  • 8
    • 0025234781 scopus 로고
    • Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation
    • Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Trainequ R, Bourdeau-Esperou H, et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol. 1990;74:277-81.
    • (1990) Br J Haematol. , vol.74 , pp. 277-281
    • Gluckman, E.1    Jolivet, I.2    Scrobohaci, M.L.3    Devergie, A.4    Trainequ, R.5    Bourdeau-Esperou, H.6
  • 9
    • 0025016567 scopus 로고
    • A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation
    • Bearman SI, Hinds MS, Wolford JL, Peterson FB, Nugent DC, Slichter SJ, et al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant. 1990;5:407-11.
    • (1990) Bone Marrow Transplant. , vol.5 , pp. 407-411
    • Bearman, S.I.1    Hinds, M.S.2    Wolford, J.L.3    Peterson, F.B.4    Nugent, D.C.5    Slichter, S.J.6
  • 10
    • 0021335877 scopus 로고
    • Ursodeoxycholic acid: A review of its pharmacological properties and therapeutic efficacy
    • Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs. 1984;27:95-131.
    • (1984) Drugs , vol.27 , pp. 95-131
    • Ward, A.1    Brogden, R.N.2    Heel, R.C.3    Speight, T.M.4    Avery, G.S.5
  • 11
    • 0020318866 scopus 로고
    • Ursodeoxcholic acid in the treatment of cholesterol cholilithiasis. Part I
    • Bachrach WH, Hofmann AF. Ursodeoxcholic acid in the treatment of cholesterol cholilithiasis. Part I. Dig Dis Sci. 1982;27:737-61.
    • (1982) Dig Dis Sci. , vol.27 , pp. 737-761
    • Bachrach, W.H.1    Hofmann, A.F.2
  • 12
    • 0022397043 scopus 로고
    • Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man
    • Parquet M, Metman EH, Raizman A, Rambaud JC, Berthaux N, Infante R. Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man. Eur J Clin Invest. 1985;15:171-8.
    • (1985) Eur J Clin Invest. , vol.15 , pp. 171-178
    • Parquet, M.1    Metman, E.H.2    Raizman, A.3    Rambaud, J.C.4    Berthaux, N.5    Infante, R.6
  • 13
    • 0025876404 scopus 로고
    • A multicenter trial of ursodiol for the treatment of primary biliary cirrhosis
    • UDCA-PBC Study Group
    • Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med. 1991;324:1548-54.
    • (1991) N Engl J Med. , vol.324 , pp. 1548-1554
    • Poupon, R.E.1    Balkau, B.2    Eschwege, E.3    Poupon, R.4
  • 14
    • 0029127685 scopus 로고
    • A randomized, double-blind, placebo-controlled trial of ursodeoxycolic acid in primary biliary cirrhosis
    • Combes B, Carithers RL Jr, Maddrey WC, Lin D, McDonald MF, Wheeler DE, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycolic acid in primary biliary cirrhosis. Hepatology. 1995;22:759-66.
    • (1995) Hepatology , vol.22 , pp. 759-766
    • Combes, B.1    Carithers Jr., R.L.2    Maddrey, W.C.3    Lin, D.4    McDonald, M.F.5    Wheeler, D.E.6
  • 16
    • 0003707376 scopus 로고    scopus 로고
    • Montvale, NJ: Medical Economics
    • Red Book. Montvale, NJ: Medical Economics; 1997.
    • (1997) Red Book
  • 17
    • 0026779860 scopus 로고
    • Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients
    • Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Callander NS, et al. Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients. Bone Marrow Transplant. 1992;10:367-72.
    • (1992) Bone Marrow Transplant. , vol.10 , pp. 367-372
    • Essell, J.H.1    Thompson, J.M.2    Harman, G.S.3    Halvorson, R.D.4    Snyder, M.J.5    Callander, N.S.6
  • 19
    • 0023574955 scopus 로고
    • Bone marrow transplantation for leukemia following a new busulfan and cydophosphamide regimen
    • Tutschka PJ, Copeland EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cydophosphamide regimen. Blood. 1987;70:1382-8.
    • (1987) Blood , vol.70 , pp. 1382-1388
    • Tutschka, P.J.1    Copeland, E.A.2    Klein, J.P.3
  • 20
    • 24244433329 scopus 로고
    • Bone marrow transplantation in multiple myeloma with busulfan and cyclophosphamide: Unacceptable toxicity with standard dose in heavily pretreated patients
    • Raybon K, Thomas A, Schroeder M, Lewis S, Christman K, Wilks S, et al. Bone marrow transplantation in multiple myeloma with busulfan and cyclophosphamide: unacceptable toxicity with standard dose in heavily pretreated patients [Abstract]. Blood. 1995;86(Suppl 1):961a.
    • (1995) Blood , vol.86 , Issue.1 SUPPL.
    • Raybon, K.1    Thomas, A.2    Schroeder, M.3    Lewis, S.4    Christman, K.5    Wilks, S.6
  • 21
    • 0026030566 scopus 로고
    • Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis
    • Deeg JH, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant. 1991;7:193-8.
    • (1991) Bone Marrow Transplant. , vol.7 , pp. 193-198
    • Deeg, J.H.1    Spitzer, T.R.2    Cottler-Fox, M.3    Cahill, R.4    Pickle, L.W.5
  • 22
    • 24244447630 scopus 로고
    • Directed ganciclovir prophylaxis against cytomegalovirus pneumonitis in patients undergoing allogeneic bone marrow transplantation
    • Schroeder M, Essell J, Harman G, Halvorson R, Dolan M, Callander N, et al. Directed ganciclovir prophylaxis against cytomegalovirus pneumonitis in patients undergoing allogeneic bone marrow transplantation [Abstract]. Blood. 1993;82(Suppl 1):425a.
    • (1993) Blood , vol.82 , Issue.1 SUPPL.
    • Schroeder, M.1    Essell, J.2    Harman, G.3    Halvorson, R.4    Dolan, M.5    Callander, N.6
  • 23
    • 0016187133 scopus 로고
    • Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
    • Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
    • (1974) Transplantation , vol.18 , pp. 295-304
    • Glucksberg, H.1    Storb, R.2    Fefer, A.3    Buckner, C.D.4    Neiman, P.E.5    Clift, R.A.6
  • 25
    • 0027412015 scopus 로고
    • On the reliability of clinical criteria for the diagnosis of hepatic venoocclusive disease
    • Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J, et al. On the reliability of clinical criteria for the diagnosis of hepatic venoocclusive disease. Ann Hematol. 1993;66:77-80.
    • (1993) Ann Hematol. , vol.66 , pp. 77-80
    • Carreras, E.1    Granena, A.2    Navasa, M.3    Bruguera, M.4    Marco, V.5    Sierra, J.6
  • 26
    • 0029057466 scopus 로고
    • Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings
    • Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant. 1995;15:853-8.
    • (1995) Bone Marrow Transplant. , vol.15 , pp. 853-858
    • Mehta, J.1    Powles, R.2    Horton, C.3    Milan, S.4    Singhal, S.5    Treleaven, J.6
  • 27
    • 0029011780 scopus 로고
    • The syndrome of hepatic veno-occlusive disease after marrow transplantation
    • Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85:3005-20.
    • (1995) Blood , vol.85 , pp. 3005-3020
    • Bearman, S.I.1
  • 28
    • 13344250481 scopus 로고    scopus 로고
    • Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia
    • Rozman C, Carreras E, Qian C, Gale R, Bortin MM, Rowlings PA, et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant. 1996;17: 75-80.
    • (1996) Bone Marrow Transplant. , vol.17 , pp. 75-80
    • Rozman, C.1    Carreras, E.2    Qian, C.3    Gale, R.4    Bortin, M.M.5    Rowlings, P.A.6
  • 29
    • 0024345093 scopus 로고
    • Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
    • Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R, et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol. 1989;25:55-61.
    • (1989) Cancer Chemother Pharmacol. , vol.25 , pp. 55-61
    • Grochow, L.B.1    Jones, R.J.2    Brundrett, R.B.3    Braine, H.G.4    Chen, T.L.5    Saral, R.6
  • 30
    • 24244457634 scopus 로고    scopus 로고
    • Busulfan pharmacokinetics in patients undergoing allogeneic bone marrow transplant: An analysis of the effects of ursodiol
    • Schroeder M, Jaslowski A, Thomas A, Warren T, Lewis S, Essell J, et al. Busulfan pharmacokinetics in patients undergoing allogeneic bone marrow transplant: an analysis of the effects of ursodiol [Abstract]. Blood. 1996; 88(Suppl 1):259b.
    • (1996) Blood , vol.88 , Issue.1 SUPPL.
    • Schroeder, M.1    Jaslowski, A.2    Thomas, A.3    Warren, T.4    Lewis, S.5    Essell, J.6
  • 31
    • 0027980844 scopus 로고
    • Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
    • Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood. 1994;84:2036-43.
    • (1994) Blood , vol.84 , pp. 2036-2043
    • Clift, R.A.1    Buckner, C.D.2    Thomas, E.D.3    Bensinger, W.I.4    Bowden, R.5    Bryant, E.6
  • 32
    • 0024467084 scopus 로고
    • Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis
    • Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology. 1989;10:414-9.
    • (1989) Hepatology , vol.10 , pp. 414-419
    • Batta, A.K.1    Salen, G.2    Arora, R.3    Shefer, S.4    Tint, G.S.5    Abroon, J.6
  • 34
    • 0024413613 scopus 로고
    • Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: Effect of ursodeoxycholic treatment
    • Chretien Y, Poupon R, Gherardt MF, Chazouilleres O, Labbe D, Myera A, et al. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment. Gut. 1989;30: 1110-5.
    • (1989) Gut , vol.30 , pp. 1110-1115
    • Chretien, Y.1    Poupon, R.2    Gherardt, M.F.3    Chazouilleres, O.4    Labbe, D.5    Myera, A.6
  • 35
    • 0025257161 scopus 로고
    • Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis
    • Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology. 1990;98:1044-50.
    • (1990) Gastroenterology , vol.98 , pp. 1044-1050
    • Podda, M.1    Ghezzi, C.2    Battezzati, P.M.3    Crosignani, A.4    Zuin, M.5    Roda, A.6
  • 37
    • 0029979135 scopus 로고    scopus 로고
    • Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats
    • Bellentani S, Chao YC, Ferretti I, Panini R, Tiribelli C. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats. Biochem Biophys Res Commun. 1996;220:479-83.
    • (1996) Biochem Biophys Res Commun. , vol.220 , pp. 479-483
    • Bellentani, S.1    Chao, Y.C.2    Ferretti, I.3    Panini, R.4    Tiribelli, C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.